Hello all,
This answer from VW may interest you :
"
Vany
a day ago
Hello,
A recent study shows that "C60-olive oil solutions are sensitive to light and that commercially available options show evidence of degradation due to light, which may cause them to become toxic"
http://www.weyburnreview.com/n...
How do you handle this degradation due to light ?
thanks
Reply
−
Avatar
Sarah Vaughter Vany
a day ago
Firstly, this "research" by Ichor Therapeutics, a competitor of ours in the C60 anticancer/antiaging sphere, is highly questionable, especially because they did not publish it for peer review. It is possible that some of the more amateuristic vendors of C60 used impure, cheaper C60 and/or mixed the product under the influence of light, but still, the only risk of light exposure is rancidity, when pure C60 is used (without organic solvents). I would like to read their secret "study". As you know, most "research" done nowadays is not reproducable. To me it seems as if that company spreads FUD (fear, uncertainty, doubt) to guide potential customers towards their own products instead.
It is highly unlikely that this company has done mutagenicity studies on various commercially available C60-EVOO formulations for a variety of reasons, this is why I question the thruthfullness of their so far wholly unsubstantiated claims. It seems as if the real purpose of their claim is an aim to establish themselves as the sole vendor of a FDA regulated product.
The reason that this company comes with the allegation that competing products with their own planned c60 product "massively cause cancer" is because this NYC startup apparently aims to monopolize the market with their own, much more expensive, FDA-regulated anti-tumor product they're developing, of which manufacturing method, origin, composition and preparation are so far unpatented trade secrets. You just have to take them on their word that all C60-EVOO products made exactly as in the rat study (that prevented all cancer!) "massively cause cancer" but that their so-far-vaporware product "doesn't". Without giving any evidence whatsoever for neither claims.
Secondly, of course we protect our product against light, since it is an olive oil product and it would be foolish in the extreme to allow this very expensive product to be exposed to light, since rancidity would be the inevitable result, since the mixing takes such a long time. Since we can't sell rancid oil, this would mean that we'd have to discard the C60 inside the product as well, and C60 costs about the same as 24 carat gold powder of the same weight. A lot of useless batches would be the result. As we explain on our site, the product is mixed in a dark room in Swedish Lapland, in dark vessels and packaged in brown bottles and then stored in a dark, cold room in Swedish Lapland. On a "just in time" basis, the product is then shipped to the Czech Republic, where it is stored for no longer than two to four weeks in a dark unheated cellar in a house with massive stone walls, keeping cool even in summer. The bottles are packed with two in cardboard tubes and those tubes again are in large boxes.
Also, the C60 we purchase is "baked" by us in a vacuum oven to be absolutely certain that there really are no remaining solvents.
What we need to know is: What C60 did they buy and where, what product did they prepare with it and how, to what intensity and wavelength light did they expose the product and for how long, and how did they come up with a cancer-cuasing property of the resulting product. Because if you use impure C60, that by itself is carcinogenic, of course, due to the solvents used. The C60-EVOO used in the rat trial was highly anti-mutagenic and our product is prepared with even more care and stored cool (the rat study kept it out of the fridge for 6 years).
Ichor Therapeutics is trying to monopolize C60's anti-cancer properties as a licensed drug and part of their efforts is to get existing, unlicensed products off the market. It is hard to do this via FDA action, so instead they're spreading fear, uncertainty and doubt. It would be pointless to get hundreds of millions in funding for a product that's available online for a few dollars.
"